Modes of action at target sites

Natural Products from Plants, Second Edition

Volumn , Issue , 2016, Pages 415-440

  Warber, Sara L ^a   Seymour, Mitchell ^a   Kaufman, Peter B ^a   Kirakosyan, Ara ^a   Cseke, Leland J ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF ALABAMA IN HUNTSVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85129583293     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (129)

1. Barnes, S. (1995). Effect of genistein on in vitro and in vivo models of cancer. J Nutr 125:777S-783S.
2. Barnes, S. and T.G. Peterson. (1995). Biochemical targets of the isoflavone genistein in tumor cell lines. Proc Exp Biol Med 208: 109-115.
3. Bensky, D. and S. Foster. (1986). Chinese Herbal Medicine. Materia Medica. Eastland Press, Seattle, Washington.
4. Bhardwaj, R.K., H. Glaeser, L. Becquemont, U. Klotz, S.K. Gupta, and M.F. Fromm. (2002). Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 302: 645-650.
5. Bisset, N.G. (Ed.). (1994). Herbal Drugs and Phytopharmaceuticals. Medpharm, Stuttgart, Germany; CRC Press, Boca Raton, Florida.
6. Boik, J. (1996). Cancer and Natural Medicine. Oregon Medical Press, Princeton, Minnesota.
7. Bourrie, M., V. Meunier, Y. Berger, and G. Fabre. (1996). Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. J Pharmacol Exp Ther 277: 321-332.
8. Brazier, N.C. and M.A. Levine. (2003). Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals. Am J Ther 10: 163-169.
9. Breinholt, V., S.T. Lauridsen, and L.O. Dragsted. (1999). Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat. Xenobiotica 29: 1227-1240.
10. Breinholt, V.M., E.A. Offord, C. Brouwer, S.E. Nielsen, K. Brosen, and T. Friedberg. (2002). In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids. Food Chem Toxicol 40: 609-616.
11. Budzinski, J.W., B.C. Foster, S. Vandenhoek, and J.T. Arnason. (2000). An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 7: 273-282.
12. Bussing, A. et al. (1996). Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins. Canc Lett 99: 59-72.
13. Butterweck, V., H. Derendorf, W. Gaus, A. Nahrstedt, V. Schulz, and M. Unger. (2004). Pharmacokinetic herb-drug interactions: are preventive screenings necessary and appropriate? Planta Med 70: 784-791.
14. Carrillo, J.A., M. Christensen, S.I. Ramos, C. Alm, M.L. Dahl, J. Benitez, and L. Bertilsson. (2000). Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine. Ther Drug Monit 22: 409-417.
15. Castiglioni, S. et al. (1993). Rhein inhibits glucose uptake in ehrlich ascites tumor cells by alteration of membrane-associated functions. Anti-Cancer 4: 407-414.
16. Chang, T.K., J. Chen, and S.A. Benetton. (2002). In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1. Drug Metab Dispos 30: 378-384.
17. Chatterjee, S.S., S.K. Bhattacharya, M. Wonnemann, A. Singer, and W.E. Muller. (1998). Hyperforin as a possible antidepressant component of hypericum extracts. Life Sci 63: 499-510.
18. Chen, Z.Y., C.C. White, and D.L. Eaton. (1993). Decreased expression of cytochrome P450 mRNAs and related steroid hydroxylation activities in hepatic hyperplastic nodules in male F344 rats. Toxicol Appl Pharmacol 123: 151-159.
19. Combs, S.P. (1997). Acute anticholinergic syndrome: Jimson weed strikes again. Res Staff Phys 43: 54-57.
20. Cotran, R.S., V. Kumar, and S.L. Robbins. (1989a). In Robbins Pathologic Basic of Disease. Cotran, R.S., Kumar, V., Collins, T., and Robbins, S.L., Eds., W.B. Saunders, Philadelphia, Pennsylvania, pp. 520-522.
21. Cotran, R.S., V. Kumar, and S.L. Robbins. (1989b). In Robbins Pathologic Basic of Disease. Cotran, R.S., Kumar, V., Collins, T., and Robbins, S.L., Eds., W.B. Saunders, Philadelphia, Pennsylvania, pp. 267-272.
22. Dickson, E.F.G., R.L. Goyan, and R.H. Pottier. (2003). New directions in photodynamic therapy. Cell and Mol Biol 48: 939-954.
23. Dierbach, H., cited in Tragni, E., C.L. Galli, et al. (1988). Antiinflammatory activity of Echinacea angustifolia fractions separated on the basis of molecular weight. Pharm Res Comm 20 (Suppl. 5): 87-90.
24. Dolmans, D.E.J.G.J., D. Fukumura, and R.K. Jain. (2003). Photodynamic therapy for cancer. Nat Rev Cancer 3: 380-387.
25. Donato, M.T. and J.V. Castell. (2003). Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies. Clin Pharmacokinet 42: 153-178.
26. Doostdar, H., M.D. Burke, and R.T. Mayer. (2000). Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology 144: 31-38.
27. Dwyer, P.J. et al. (1986). Homoharringtonine - perspectives on an active new natural product. J Clin Oncol 4: 1563-1568.
28. Epstein, W.L. (1987). Plant-induced dermatitis. Annals Emer Med 16: 950-955.
29. Forman, B.M. (2001). Polymorphisms in promiscuous PXR: an explanation for interindividual differences in drug clearance? Pharmacogenetics 11: 551-552.
30. Foster, B.C., M.S. Foster, S. Vandenhoek, A. Krantis, J.W. Budzinski, J.T. Arnason, K.D. Gallicano, and S. Choudri. (2001). An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. J Pharm Pharm Sci 4: 176-184.
31. Foster, B.C., S. Vandenhoek, J. Hana, A. Krantis, M.H. Akhtar, M. Bryan, J.W. Budzinski, A. Ramputh, and J.T. Arnason. (2003). In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products. Phytomedicine 10: 334-342.
32. Foster, S. (1995). Echinacea: the cold and flu remedy. Altern Compl Ther June/July, 254-257.
33. Fotis, T. et al. (1995). Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 125: 790S-797S.
34. Gilmore, M.R. (1919). Thirty-third annual report of the Bureau of American Ethnology, U.S. Government Printing Office, Washington, D.C.
35. Girolomoni, G. and R.E. Tigelaar. (1990). Capsaicin-sensitive primary sensory neurons are potent modulators of murine delayed-type hypersensitivity reaction. J Immunol 145: 1105-1112.
36. Gorski, J.C., S.M. Huang, A. Pinto, M.A. Hamman, J.K. Hilligoss, N.A. Zaheer, M. Desai, M. Miller, and S.D. Hall. (2004). The effect of echinacea (Echinacea purpurea) root on cytochrome P450 activity in vivo. Clin Pharmacol Ther 75: 89-100.
37. Gowda, D.C., B. Neelisiddaiah, and Y.V. Anjaneyalu. (1979). Structural studies of polysaccharides from Aloe vera. Carbohyd Res 72: 201-205.
38. Griffiths, C.E.M., J.N.W.N. Barker, S. Kunkel, and B.J. Nickoloff. (1991). Modulation of leucocyte adhesion molecules, a T-cell chemotoxin (IL-8) and a regulatory cytokine (TNF-ol) in allergic contact dermatitis (rhus dermatitis). Brit J Dermat 124: 519-526.
39. Grindlay, D. and T. Reynolds. (1986). The Aloe vera phenomenon: a review of the properties and modern uses of the leaf parenchyma gel. J Ethnopharm 16: 117-151.
40. Hennessy, M., D. Kelleher, J.P. Spiers, M. Barry, P. Kavanagh, D. Back, F. Mulcahy, and J. Feely. (2002). St. John's wort increases expression of P-glycoprotein: implications for drug interactions. Br J Clin Pharmacol 53: 75-82.
41. Ho, P.C., D.J. Saville, and S. Wanwimolruk. (2001). Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. J Pharm Pharm Sci 4: 217-227.
42. Honkakoski, P., T. Sueyoshi, and M. Negishi. (2003). Drug-activated nuclear receptors CAR and PXR. Ann Med 35: 172-182.
43. Huang, D.Y., T. Ohnishi, H. Jiang, A. Furukawa, and Y. Ichikawa. (1999). Inhibition by retinoids of ben-zo(A)pyrene metabolism catalyzed by 3-methylcholanthrene-induced rat cytochrome P-450 1A1. Metabolism 48: 689-692.
44. Huynh, H.T. and R.W. Teel. (2002). Effects of plant-derived phenols on rat liver cytochrome P450 2B1 activity. Anticancer Res 22: 1699-1703.
45. Imanishi, K. et al. (1981). Pharmacological studies on a plant lectin, aloctin A. I. Growth inhibition of mouse methylcholanthrene-induced fibrosarcoma (meth A) in ascites form by aloctin A. Experienta 37: 1186-1187.
46. Iosi, F., M.T. Santini, and W. Malorni. (1993). Membrane and cytoskeleton are intracellular targets of rhein in A431 cells. Anticancer Res 13: 545-554.
47. Janssen, O., A. Scheffler, and D. Kabelitz. (1993). In vitro effects of mistletoe extracts and mistletoe lectins. Arzneim-Forsch/Drug Res 43: 1221-1227.
48. Juckett, G. (1996). Plant dermatitis. Prostgrad Med 100: 159-171.
49. Jump, D.B., A. Thelen, and M. Mater. (1999). Dietary polyunsaturated fatty acids and hepatic gene expression. Lipids 34: S209-S212.
50. Kalish, R.S. (1990). The use of human T-lymphocyte clones to study T-cell function in allergic contact dermatitis to urushiol. J Invest Dermat 94: 108S-111S.
51. Kang, M.H., S.M. Won, S.S. Park, S.G. Kim, R.F. Novak, and N.D. Kim. (1994). Piperine effects on the expression of P4502E1, P4502B and P4501A in rat. Xenobiotica 24: 1195-1204.
52. Karaca, K., J.M. Sharma, and R. Nordgren. (1995). Nitric oxide production by chicken macrophages activated by acemannan, a complex carbohydrate extracted from Aloe vera. Int J Immunopharm 17: 183-188.
53. Klein, A.D. and N.S. Penneys. (1988). Aloe vera. J Am Acad Dermatol 18: 714-720.
54. Koike, T. et al. (1995a). A 35 kDa mannose-binding lectin with jemagglutinating and mitogenic activities from "Kidachi Aloe" (Aloe arborescens Miller var. natalensis Berger). J Biochem (Tokyo) 118: 1205-1210.
55. Koike, T. et al. (1995b). The complete amino acid sequence of a mannose-binding lectin from "Kidachi Aloe" (Aloe arborescens Miller var. natalensis Berger). Biochem Biophys Res Comm 214: 163-170.
56. Komoroski, B.J., S. Zhang, H. Cai, J.M. Hutzler, R. Frye, T.S. Tracy, S.C. Strom, T. Lehmann, C.Y. Ang, Y.Y. Cui, and R. Venkataramanan. (2004). Induction and inhibition of cytochromes p450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. Drug Metab Dispos 32: 512-518.
57. Koul, S., J.L. Koul, S.C. Taneja, K.L. Dhar, D.S. Jamwal, K. Singh, R.K. Reen, and J. Singh. (2000). Structure-activity relationship of piperine and its synthetic analogues for their inhibitory potentials of rat hepatic microsomal constitutive and inducible cytochrome P450 activities. Bioorg Med Chem 8: 251-268.
58. Kuong, D.D., A.I. Dovgii, N.V. Adrianov, A.I. Varenitsa, and A.I. Archakov. (1991). Induction of cytochrome P-450 by triterpensaponins in Vietnamese ginseng. Biokhimiia 56: 707-713.
59. Lau, W.C., P.A. Gurbel, P.B. Watkins, C.J. Neer, A.S. Hopp, D.G. Carville, K.E. Guyer, A.R. Tait, and E.R. Bates. (2004). Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance. Circulation 109: 166-171.
60. Lavie, G., A. Toren, D. Meruelo, R. Stackievicz, S. Hazen, and M. Mandel. (1998). Photodynamic dianthrones in PDT. Dimethyl-tetrahydroxy helianthrone (DTHe) and hypericin (HY). Mode of Action. 7th Biennial Congress of IPA, July 1998, Nantes, France. Congress Reports, RC23.
61. Lee, H.C., S.G. Hwang, Y.G. Lee, H.O. Sohn, D.W. Lee, S.Y. Hwang, Y.S. Kwak, J.J. Wee, W.H. Joo, Y.K. Cho, and J.Y. Moon. (2002). In vivo effects of Panax ginseng extracts on the cytochrome P450-dependent monooxygenase system in the liver of 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed guinea pig. Life Sci 71: 759-769.
62. Lehmann, J.M., D.D. McKee, M.A. Watson, T.M. Willson, J.T. Moore, and S.A. Kliewer. (1998). The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102: 1016-1023.
63. Lersch, C. et al. (1990). Stimulation of the immune response in outpatients with hapatocellular carcinomas by low doses of cyclophosphamide (LDCY), Echinacea purpurea extracts (echinacin) and thymostimulin. Archives Geschwulstforsch 60: 379-383.
64. Lersch, C. et al. (1992). Nonspecific immunostimulation with low doses of cyclophosphamide (LDCY), thymostimulin, and Echinacea purpurea extracts (echinacin) in patients with far advanced colorectal cancers: preliminary results. Canc Invest 10: 343-348.
65. Leung, A.Y. and S. Foster. (1996). Encyclopedia of Common Natural Ingredients, 2nd ed. John Wiley & Sons, New York.
66. Lewis, W.H. and M.P.F. Elvin-Lewis. (1977a). Cell modifiers: mutagens, teratogens, and lectins. In Medical Botany, Plants Affecting Man's Health. John Wiley & Sons, New York, pp. 90-96.
67. Lewis, W.H. and M.P.F. Elvin-Lewis. (1977b). Cancer. In Medical Botany, Plants Affecting Man's Health. John Wiley & Sons, New York, pp. 120-121.
68. Linde, K. and C.D. Mulrow. (2003). St. John's wort for depression. Cochrane Database Systematic Reviews 2, CD000448.
69. Linde, K., G. Ramirez, C.D. Mulrow, et al. (1996). St. John's wort for depression - an overview and metaanalysis of randomized clinical trials. Brit Med J 313: 253-258.
70. Loizou, G.D. and J. Cocker. (2001). The effects of alcohol and diallyl sulphide on CYP2E1 activity in humans: a phenotyping study using chlorzoxazone. Hum Exp Toxicol 20: 321-327.
71. Lubart, R., M. Eichler, R. Lovi, H. Friedman, and A. Shainberg. (2005). Low-energy laser irradiation promotes cellular redox activity. Photomed and Laser Surg 23: 3-9.
72. Lucas, D., R. Ferrara, E. Gonzalez, P. Bodenez, A. Albores, M. Manno, and F. Berthou. (1999). Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans. Pharmacogenetics 9: 377-388.
73. Luettig, B. et al. (1989). Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. J Nat Canc Inst 81: 669-675.
74. Markovits, J. et al. (1989). Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II.. Canc Res 49: 5111-5117.
75. Markovits, J. et al. (1995). Genistein resistance in human leukaemic CCRF-CEM cells: selection of a diploid cell line with reduced DNS topoisomerase II B isoform. Biochem Pharm 50: 177-186.
76. Markowitz, J.S., J.L. Donovan, C.L. DeVane, R.M. Taylor, Y. Ruan, J.S. Wang, and K.D. Chavin. (2003). Effect of St. John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 290: 1500-1504.
77. McDermott, W.V. and P.M. Ridker. (1990). The Budd-Chiari syndrome and hepatic venoocclusive disease. Arch Surg 125: 525-527.
78. McManus, O.B. et al. (1993). An activator of calcium-dependent potassium channels isolated from a medicinal herb. Biochemistry 32: 6128-6133.
79. Mennini, T. and M. Gobbi. (2004). The antidepressant mechanism of Hypericum perforatum. Life Sci 75: 1021-1027.
80. Moore, L.B., B. Goodwin, S.A. Jones, G.B. Wisely, C.J. Serabjit-Singh, T.M. Willson, J.L. Collins, and S.A. Kliewer. (2000). St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 97: 7500-7502.
81. Nielsen, S.E., V. Breinholt, U. Justesen, C. Cornett, and L.O. Dragsted. (1998). In vitro biotransformation of flavonoids by rat liver microsomes. Xenobiotica 28: 389-101.
82. Noldner, M. and K. Schotz. (2002). Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test. Planta Med 68: 577-580.
83. Obach, R.S. (2000). Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther 294: 88-95.
84. Ohnuma, T. and J.F. Holland. (1985). Homoharringtonine as a new antileukemic agent. J Clin Oncol 73: 604-606.
85. Olin, B.R. (Ed.). (1995a). The ephedras. The Lawrence Review of Natural Products. Facts and Comparisons. Kluwer, St. Louis, Missouri.
86. Olin, B.R. (Ed.). (1995b). Comfrey. The Lawrence Review of Natural Products. Facts and Comparisons. Kluwer, St. Louis, Missouri.
87. Oliver, F. et al. (1995). Contact urticaria due to common stinging nettle (Urtica dioica) - histological, ultrastructural and pharmacological studies. Clin Exp Dermatol 16: 1-7.
88. Pass, G.J. and S. McLean. (2002). Inhibition of the microsomal metabolism of 1,8-cineole in the common brushtail possum (Trichosurus vulpecula) by terpenes and other chemicals. Xenobiotica 32: 1109-1126.
89. Pazdur, R. et al. (1993). The taxoids: paclitaxel (Taxol®) and docetaxel (Taxotere®). Canc Treat Rev 19: 351-386.
90. Peng, S.Y. et al. (1991). Decreased mortality of Norman murine sarcoma in mice treated with the immunomodulator, acemannan. Mol Biother 3: 79-87.
91. Peterson, G. (1995). Evaluation of the biochemical targets of genistein in tumor cells. J Nutr 125: 784S-789S.
92. Quick, G. (1995). Scratching below the surface of poison ivy rash. Consultant 34: 545-549.
93. Rivory, L.P., K.A. Slaviero, J.M. Hoskins, and S.J. Clarke. (2001). The erythromycin breath test for the prediction of drug clearance. Clin Pharmacokinet 40: 151-158.
94. Roby, C.A., G.D. Anderson, E. Kantor, D.A. Dryer, and A.H. Burstein. (2000). St. John's Wort: effect on CYP3A4 activity. Clin Pharmacol Ther 67: 451-457.
95. Roesler, J. et al. (1991a). Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to test subjects mediates activation of the phagocyte system. Int J Immunopharm 13: 931-941.
96. Roesler, J. et al. (1991b). Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to mice mediates protection against systemic infections with Listeria monocytogenes and Candida albicans. Int J Immunopharm 13: 27-37.
97. Roitt, J.M., J. Brostoff, and D.K. Mala. (1985). Hypersensitivity-Type I, Secs. 19.2-19.11. In Immunology. C.V. Mosby, St. Louis, Missouri.
98. Rowe, T.D. and L.M. Parks. (1941). Phytochemical study of Aloe vera leaf. J Am Pharm Assoc 30: 262-266.
99. Rowinsky, E.K., L.A. Cazenave, and R.C. Donehower. (1990). Taxol: a novel investigational antimicrotubule agent. J Nat Canc Inst 82: 1247-1259.
100. Runowicz, C.D. et al. (1993). Taxol in ovarian cancer. Canc (Suppl) 71: 1591-1596.
101. Salmon, S.E. and A.C. Sartorelli. (1989). Cancer chemotherapy. In Basic and Clinical Pharmacology. B.G. Katzung (Ed.). Appleton-Lange, Norwalk, Connecticut, p. 694.
102. Shelton, R.M. (1991). Aloe vera: its chemical and therapeutic properties. Int J Dermatol 30: 679-683.
103. Smith, K.C. (2005). Laser (and LED) therapy is phototherapy. Photomed and Laser Surg 23: 78-80.
104. Southcott, R.V. and A.R. Haegi. (1992). Plant hair dermatitis. Med J Aust 156: 623-632.
105. Steinmuller, C. et al. (1993). Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida albicans, and Listeria monocytogenes. Int J Immunopharm 15: 605-614.
106. Stimpel, M. et al. (1984). Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharide fractions from the plant, Echinacea purpurea. Infec Immunol 46: 845-849.
107. Strandell, J., A. Neil, and G. Carlin. (2004). An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies. Phytomedicine 11: 98-104.
108. Streetman, D.S., J.S. Bertino, Jr., and A.N. Nafziger. (2000). Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes. Pharmacogenetics 10: 187-216.
109. Stresser, D.M., G.S. Bailey, and D.E. Williams. (1994). Indole-3-carbinol and -naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of anatoxin B1 in the rat. Drug Metab Dispos 22: 383-391.
110. Vandebogaerde, A.L. et al. (1996). Antitumor activity of photosensitized hypericin on A431 cell xenografts. Anticanc Res 16: 1619-1626.
111. Vanderwerf, W.M. et al. (1996). Hypericin: a new laser phototargeting agent for human cancer cells. Laryngoscope 106: 479-482.
112. van Wyk, B.E., M.C. van Rheede van Oudtshoorn, and G.F. Smith. (1995). Geographical variation in the major compounds of Aloe ferox leaf exudate. Plant Med 61: 250-253.
113. Verotta, L., G. Appendino, J. Jakupovic, and E. Bombardelli. (2000). Hyperforin analogues from St. John's wort (Hypericum perforatum). J Nat Prod 63: 412-415.
114. Wang, H.W., T.L. Chen, P.C. Yang, and T.H. Ueng. (2001). Induction of cytochromes P450 1A1 and 1B1 by emodin in human lung adenocarcinoma cell line CL5. Drug Metab Dispos 29: 1229-1235.
115. Wang, Y.G., Y. Gao, B.X. Chai, P. Chen, H.L. Tan, Y.H. Zhao, C.R. Xiao, Y.Y. Sun, and L.J. Zhu. (2004). [Modulation of the activities and mRNA expression of cytochrome P450 isoenzymes in rat liver by Panax gingseng and coadministration with Veratrum nigrum]. Zhongguo Zhong Yao Za Zhi 29: 366-370.
116. Wang, Z., J.C. Gorski, M.A. Hamman, S.M. Huang, L.J. Lesko, and S.D. Hall. (2001). The effects of St. John's wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther 70: 317-326.
117. Wieling, J., W.J. Tamminga, E.P. Sakiman, B. Oosterhuis, J. Wemer, and J.H. Jonkman. (2000). Evaluation of analytical and clinical performance of a dual-probe phenotyping method for CYP2D6 polymorphism and CYP3A4 activity screening. Ther Drug Monit 22: 486-496.
118. Wikvall, K. (2001). Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (review). Int J Mol Med 7: 201-209.
119. Williams, J.A., E.M. Stone, B.C. Millar, B.A. Gusterson, P.L. Grover, and D.H. Phillips. (1998). Determination of the enzymes responsible for activation of the heterocyclic amine 2-amino-3-methylimidazo[4,5f]quinoline in the human breast. Pharmacogenetics 8: 519-528.
120. Williams, S.R., R.F. Clark, and J.V. Dunford. (1995). Contact dermatitis associated with capsaicin: Hunan hand syndrome. Annals Emer Med 25: 713-715.
121. Wilson, B.C. (2002). Photodynamic therapy for cancer: principles. Can J Gastroenterol 16: 393-396.
122. Wirz, A., U. Simmen, J. Heilmann, I. Calis, B. Meier, and O. Sticher. (2000). Bisanthraquinone glycosides of Hypericum perforatum with binding inhibition to CRH-1 receptors. Phytochem 55: 941-947.
123. Woods, B. and C.D. Calnan. (1976). Toxic woods. Br J Derma 95: 1-95.
124. Yu, C.T., J. Chen, X.W. Teng, V. Tong, and T.K. Chang. (2005). Lack of evidence for induction of CYP2B1, CYP3A23, and CYP1A2 gene expression by Panax ginseng and Panax quinquefolius extracts in adult rats and primary cultures of rat hepatocytes. Drug Metab Dispos 33: 19-22.
125. Zajac, C.S. and E.L. Abel. (1992). Animal models of prenatal alcohol exposure. Int J Epidemiol 21: S24-S32.
126. Zhou, D.C., R. Zittoun, and J.P. Marie. (1995). Homoharringtonine: an effective new natural product in cancer chemotherapy. Bull Canc 82: 987-995.
127. Zhou, S., H.L. Koh, Y. Gao, Z.Y. Gong, and E.J. Lee. (2004). Herbal bioactivation: the good, the bad and the ugly. Life Sci 74: 935-968.
128. Zhu, B., D.S. Ou-Yang, X.P. Chen, S.L. Huang, Z.R. Tan, N. He, and H.H. Zhou. (2001). Assessment of cytochrome P450 activity by a five-drug cocktail approach. Clin Pharmacol Ther 70: 455-461.
129. Zwillich, T. (1996). FDA considers regulation of ephedrine as drug. Fam Prac News 1: 30.